1. Home
  2. Live Updates
  3. Gil yosipovitch

Live Breaking News & Updates on Gil yosipovitch

Stay informed with the latest breaking news from Gil yosipovitch on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Gil yosipovitch and stay connected to the pulse of your community

Neuropeptide in Blood to Help Diagnose Chronic Itch

B-type natriuretic peptide (BNP) plays a key role in chronic itch severity and can help to identify certain types of itch with a simple blood test, according t

Miami , Florida , United-states , Miller-school , Gil-yosipovitch , Brian-kim , Santosh-mishra , Mark-hoon , Leigha-nattkemper , Icahn-school-of-medicine-at-mount-sinai , National-institutes-of-health , Miami-itch-center

Why we may be hardwired to shun those who scratch

We derive pleasure from scratching an itch – but may have evolved to shun those who scratch.

San-francisco , California , United-states , Miami , Florida , New-york , Marlys-fassett , Jasmin-fox-skellyfeatures , Gil-yosipovitch , Brian-kim , University-of-miller-school-medicine , Icahn-school-of-medicine-at-mount-sinai

The new drugs that may bring an end to constant itching

While for most people, an itch is an annoying, temporary nuisance, one in five of us will experience chronic itch lasting weeks or months. New treatments finally offer hope.

California , United-states , Germany , Austria , New-york , San-francisco , German , Austrian , Gil-yosipovitch , Jasmin-fox-skellyfeatures , Marlys-fassett , Brian-kim

Gil Yosipovitch, MD: Overview of Current Research on Prurigo Nodularis

During this interview segment, Dr. Yosipovitch discussed his overview of current PN research and a specific study he had presented at EADV.


Germany , Gil-yosipovitch , Miller-school-of-medicine , University-of-miami , European-academy-of-dermatology , Miller-school , Pn , Prurigo-nodularis , Yosipovitch , Eadv , Dupilumab ,

Gil Yosipovitch, MD: New Analysis of Data on Patient Satisfaction with Dupilumab for Prurigo Nodularis

This discussion with Dr. Yosipovitch covered findings presented at EADV 2023 on dupilumab and prurigo nodularis patients’ satisfaction.


Gil-yosipovitch , European-academy-of-dermatology , University-of-miami , Miller-school-of-medicine , Miller-school , Nature-medicine , Pn , Prurigo-nodularis , Dupilumab , Satisfaction , Eadv ,

Why It Can Feel Impossible to Stop Scratching an Itch

There’s a reason it feels so maddeningly good.

Miami , Florida , United-states , China , Shenzhen , Guangdong , Berkeley , California , Gil-yosipovitch , Zhou-feng-chen , Diana-bautista , Brians-kim

Why can't you stop scratching an itch?

There’s a reason it feels so maddeningly good.

California , United-states , Berkeley , Shenzhen , Guangdong , China , Miami , Florida , Diana-bautista , Brians-kim , Gil-yosipovitch , Zhou-feng-chen

Adults, children with chronic spontaneous urticaria differ in clinical features, response

Pediatric and adult chronic spontaneous urticaria exhibit distinct features, with adolescent presentations resembling those of adults more than those of younger children, according to a study published in Pediatric Allergy and Immunology. Younger children with chronic spontaneous urticaria (CSU) also have better responses to antihistamines than adolescents and adults, suggesting more severe and

Miami , Florida , United-states , American , Sanofi-regeneron , Arcutis-biotherapeutics , Gil-yosipovitch , American-academy-of-dermatology-annual-meeting , University-of-miami-miller-school-medicine , Pfizer , Novartis , Phillip-frost-department-of-dermatology

Pierre Fabre Compiles 3.3 Million Skin-related Data Points in One Source

Pierre Fabre Compiles 3.3 Million Skin-related Data Points in One Source
cosmeticsandtoiletries.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cosmeticsandtoiletries.com Daily Mail and Mail on Sunday newspapers.

Singapore , Florida , United-states , Miller-school , Miami , Perez-cullel , Pierre-fabre , Phillip-frost , Gil-yosipovitch , Miami-itch-center-dr , Miller-school-of-medicine , World-congress

Dupilumab Benefits Shown in Phase 3 Prurigo Nodularis Trials

The results "support the involvement of type 2 cytokines in driving PN disease pathogenesis and the targeting of the IL-4/IL-13 axis as a novel therapeutic paradigm" for PN, the authors write.

Washington , United-states , Adam-friedman , Gil-yosipovitch , University-of-miami , Regeneron-pharmaceuticals , George-washington-university , Nature-medicine , Worst-itch-numeric-rating-scale , Biologic-therapy , Prurigo-nodularis , Nodule